Seemanová, Eva <br/><br/>
Cancer risk of heterozygotes with the NBN founder mutation.  [electronic resource] 

 -  Journal of the National Cancer Institute  Dec 2007 
 - 1875-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djm251  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Breast Neoplasms--epidemiology<br/>Cell Cycle Proteins--genetics<br/>Chromosome Breakage<br/>Colorectal Neoplasms--epidemiology<br/>Czech Republic--epidemiology<br/>DNA Mutational Analysis<br/>Female<br/>Founder Effect<br/>Gene Deletion<br/>Genetic Carrier Screening<br/>Genetic Predisposition to Disease<br/>Genital Neoplasms, Female--epidemiology<br/>Germ-Line Mutation<br/>Heterozygote<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--epidemiology<br/>Nijmegen Breakage Syndrome--epidemiology<br/>Nuclear Proteins--genetics<br/>Odds Ratio<br/>Research Design<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Slovakia--epidemiology<br/>Stomach Neoplasms--epidemiology